Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 70, 2006 - Issue 9
Journal homepage
130
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

RNA Interference Effectively Inhibits mRNA Accumulation and Protein Expression of Hepatitis C Virus Core and E2 Genes in Human Cells

Min LIUDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Hui DINGDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Ping ZHAODepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Zhao-Ling QINDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Jun GAODepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Ming-Mei CAODepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Jie LUANDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
,
Wen-Bin WUDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
&
Zhong-Tian QIDepartment of Microbiology, State Key Laboratory of Medical Immunology, Second Military Medical University
 show all
Pages 2049-2055 | Received 04 Jan 2006, Accepted 15 May 2006, Published online: 22 May 2014

  • 1) Hannon, G. J., RNA interference. Nature, 418, 244–251 (2002).
  • 2) Shi, Y., Mammalian RNAi for the masses. Trends Genet., 19, 9–12 (2003).
  • 3) Dykxhoorn, D. M., Novina, C. D., and Sharp, P. A., Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell. Biol., 4, 457–465 (2003).
  • 4) Vance, V., and Vaucheret, H., RNA silencing in plants: defense and counterdefense. Science, 292, 2277–2280 (2001).
  • 5) Cullen, B. R., RNA interference: antiviral defense and genetic tool. Nat. Immunol., 3, 597–599 (2002).
  • 6) Clemens, J. C., Worby, C. A., Simonson-Leff, N., Muda, M., Maehama, T., Hemmings, B. A., and Dixon, J. E., Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. USA, 97, 6499–6503 (2000).
  • 7) McManus, M. T., and Sharp, P. A., Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet., 3, 737–747 (2002).
  • 8) Bradley, D. W., Studies of non-A, non-B hepatitis and characterization of the hepatitis C virus in chimpanzees. Curr. Top. Microbiol. Immunol., 242, 1–23 (2000).
  • 9) Alter, M. J., Margolis, H. S., Krawczynski, K., Judson, F. N., Mares, A., Alexander, W. J., Hu, P. Y., Miller, J. K., Gerber, M. A., and Sampliner, R. E., The natural history of community-acquired hepatitis C in the United States: the sentinel counties chronic non-A, non-B hepatitis study team. N. Engl. J. Med., 327, 1899–1905 (1992).
  • 10) Diepolder, H. M., Jung, M. C., Keller, E., Schraut, W., Gerlach, J. T., Gruner, N., Zachoval, R., Hoffmann, R. M., Schirren, C. A., Scholz, S., and Pape, G. R., A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin. Exp. Immunol., 113, 244–251 (1998).
  • 11) Gruner, N. H., Gerlach, T. J., Jung, M. C., Diepolder, H. M., Schirren, C. A., Schraut, W. W., Hoffmann, R., Zachoval, R., Santantonio, T., Cucchiarini, M., Cerny, A., and Pape, G. R., Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J. Infect. Dis., 181, 1528–1536 (2000).
  • 12) Chisari, F. V., Cytotoxic T cells and viral hepatitis. J. Clin. Invest., 99, 1472–1477 (1997).
  • 13) Lanford, R. E., and Bigger, C., Advances in model systems for hepatitis C virus research. Virology, 293, 1–9 (2002).
  • 14) Christie, J. M., and Chapman, R. W., Combination therapy for chronic hepatitis C: interferon and ribavirin. Hosp. Med., 60, 357–361 (1999).
  • 15) McCaffrey, A. P., Ohashi, K., Meuse, L., Shen, S., Lancaster, A. M., Lukavsky, P. J., Sarnow, P., and Kay, M. A., Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Mol. Ther., 5, 676–684 (2002).
  • 16) Reed, K. E., and Rice, C. M., Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol., 242, 55–84 (2000).
  • 17) Bartenschlager, R., and Lohmann, V., Replication of hepatitis C virus. Gen. Virol., 81, 1631–1648 (2000).
  • 18) Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D., and Pawlotsky, J. M., Structural biology of hepatitis C virus. Hepatology, 39, 5–19 (2004).
  • 19) Pileri, P., Uematsu, Y., Campagnoli, S., Galli, G., Falugi, F., Petracca, R., Weiner, A. J., Houghton, M., Rosa, D., Grandi, G., and Abrignani, S., Binding of hepatitis C virus to CD81. Science, 282, 938–941 (1998).
  • 20) Crotta, S., Stilla, A., Wack, A., D’Andrea, A., Nuti, S., D’Oro, U., Mosca, M., Filliponi, F., Brunetto, R. M., Bonino, F., Abrignani, S., and Valiante, N. M., Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med., 195, 35–41 (2002).
  • 21) Tseng, C. T., and Klimpel, G. R., Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J. Exp. Med., 195, 43–49 (2002).
  • 22) Machida, K., Cheng, K. T., Pavio, N., Sung, V. M., and Lai, M. M., Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J. Virol., 79, 8079–8089 (2005).
  • 23) Zhao, L. J., Liu, H. Q., Cao, J., Feng, G. S., and Qi, Z. T., Activation of intracellular MAPK/ERK initiated by hepatitis C virus envelope protein E2 in HepG2 cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (in Chinese), 33, 691–695 (2001).
  • 24) Marathe, R., Anandalakshmi, R., Smith, T. H., Pruss, G. J., and Vance, V. B., RNA viruses as inducers, suppressors and targets of post-transcriptional gene silencing. Plant Mol. Biol., 43, 295–306 (2000).
  • 25) Hall, I. M., Shankaranarayana, G. D., Noma, K., Ayoub, N., Cohen, A., and Grewal, S. I., Establishment and maintenance of a heterochromatin domain. Science, 297, 2232–2237 (2002).
  • 26) Wilson, J. A., Jayasena, S., Khvorova, A., Sabatinos, S., Rodrigue-Gervais, I. G., Arya, S., Sarangi, F., Harris-Brandts, M., Beaulieu, S., and Richardson, C. D., RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells. Proc. Natl. Acad. Sci. USA, 100, 2783–2788 (2003).
  • 27) Cao, M. M., Ren, H., Pan, X., Pan, W., and Qi, Z. T., Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells. J. Virol. Methods, 119, 189–194 (2004).
  • 28) Rajeevan, M. S., Vernon, S. D., Taysavang, N., and Unger, E. R., Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J. Mol. Diagn., 3, 26–31 (2001).
  • 29) Winer, J., Jung, C. K., Shackel, I., and Williams, P. M., Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem., 270, 41–49 (1999).
  • 30) Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S. K., Collman, R. G., Lieberman, J., Shankar, P., and Sharp, P. A., siRNA-directed inhibition of HIV-1 infection. Nat. Med., 8, 681–686 (2002).
  • 31) Coburn, G. A., and Cullen, B. R., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol., 76, 9225–9231 (2002).
  • 32) Lee, N. S., Dohjima, T., Bauer, G., Li, H., Li, M. J., Ehsani, A., Salvaterra, P., and Rossi, J., Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol., 20, 500–505 (2002).
  • 33) Chang, J., Yang, S. H., Cho, Y. G., Hwang, S. B., Hahn, Y. S., and Sung, Y. C., Hepatitis C virus core from two different genotypes has an oncogenic potential but is not sufficient for transforming primary rat embryo fibroblasts in cooperation with the H-ras oncogene. J. Virol., 72, 3060–3065 (1998).
  • 34) Ray, R. B., Lagging, L. M., Meyer, K., and Ray, R., Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol., 70, 4438–4443 (1996).
  • 35) Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., and Koike, K., The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med., 4, 1065–1067 (1998).
  • 36) Giambartolomei, S., Covone, F., Levrero, M., and Balsano, C., Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene, 20, 2606–2610 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.